Feeds

People of Weight™ hail fat-busting miracle pill

A 'mouth-watering prospect'

  • alert
  • submit to reddit

Beginner's guide to SSL certificates

A miracle fat-busting pill which also helps people quit smoking and cuts harmful cholesterol levels has been hailed as a "mouth-watering prospect" for British GPs after two years' successful trials.

That's the verdict on rimonabant by David Haslam of the National Obesity Forum, who enthused: "This is a completely unique drug and these are very impressive results. It reduces weight, helps in quitting smoking and brings cholesterol levels down. We can really save some lives with this, as well as reducing the large costs of treating obesity and its related complications such as heart disease in the NHS."

Rimonabant works by targeting those bits of the brain which control appetite and will power. It was tested on 3000 people in the US and Canada and after two years on 20mg of the stuff, nearly two-thirds of the guinea pigs had lost weight compared to just one third of those who were on a placebo.

The drug - manufactured by Sanofi-Synthelabo under the trade name Acomplia - could be available in the UK within 18 months, which is when we reckon the real trouble starts. While it is not yet clear whether rimonabant will have positive side-effects including saving the whale and promoting peace in the Middle East, one thing is certain: global economic recession caused by the complete collapse of the junk food industry.

We can well imagine the sight of millons of former burger-flippers begging on street corners. True, they'll be lean, non-smoking former burger-flippers and will at least have the consolation that they do not have to raise funds to satisfy their appetite for chicken-in-a-bucket, fries and cigarettes, but the chilling scale of the human tragedy can only be imagined. ®

Related stories

Peruvians develop super-tasty guinea pig
S'kiddies munch Burger King
Brits move into edible Colombian ant market

Top 5 reasons to deploy VMware with Tegile

More from The Register

next story
Bond villains lament as Wicked Lasers withdraw death ray
Want to arm that shark? Better get in there quick
Antarctic ice THICKER than first feared – penguin-bot boffins
Robo-sub scans freezing waters, rocks warming models
Your PHONE is slowly KILLING YOU
Doctors find new Digitillnesses - 'text neck' and 'telepressure'
SEX BEAST SEALS may be egging each other on to ATTACK PENGUINS
Boffin: 'I think the behaviour is increasing in frequency'
Reuse the Force, Luke: SpaceX's Elon Musk reveals X-WING designs
And a floating carrier for recyclable rockets
The next big thing in medical science: POO TRANSPLANTS
Your brother's gonna die, kid, unless we can give him your, well ...
NASA launches new climate model at SC14
75 days of supercomputing later ...
Renewable energy 'simply WON'T WORK': Top Google engineers
Windmills, solar, tidal - all a 'false hope', say Stanford PhDs
Britain's HUMAN DNA-strewing Moon mission rakes in £200k
3 days, and Kickstarter moves lander 37% nearer takeoff
prev story

Whitepapers

Why cloud backup?
Combining the latest advancements in disk-based backup with secure, integrated, cloud technologies offer organizations fast and assured recovery of their critical enterprise data.
Getting started with customer-focused identity management
Learn why identity is a fundamental requirement to digital growth, and how without it there is no way to identify and engage customers in a meaningful way.
Go beyond APM with real-time IT operations analytics
How IT operations teams can harness the wealth of wire data already flowing through their environment for real-time operational intelligence.
Why CIOs should rethink endpoint data protection in the age of mobility
Assessing trends in data protection, specifically with respect to mobile devices, BYOD, and remote employees.
High Performance for All
While HPC is not new, it has traditionally been seen as a specialist area – is it now geared up to meet more mainstream requirements?